The clinical significance of soluble human leukocyte antigen class-I, ICTP, and RANKL molecules in multiple myeloma patients.
Because of the variable clinical course of multiple myeloma, the identification of prognostic parameters is of clinical interest. Therefore, we analyzed the clinical significance of serum levels of soluble human leukocyte antigen class I molecules (sHLA-I), carboxy-terminal telopeptide of type-I col...
| Principais autores: | Schütt, P, Rebmann, V, Brandhorst, D, Wiefelspütz, J, Ebeling, P, Opalka, B, Seeber, S, Nowrousian, MR, Moritz, T, Grosse-Wilde, H |
|---|---|
| Formato: | Journal article |
| Idioma: | English |
| Publicado em: |
2008
|
Registros relacionados
-
Soluble MICA as an independent prognostic factor for the overall survival and progression-free survival of multiple myeloma patients.
por: Rebmann, V, et al.
Publicado em: (2007) -
Thalidomide in combination with dexamethasone for pretreated patients with multiple myeloma: serum level of soluble interleukin-2 receptor as a predictive factor for response rate and for survival.
por: Schütt, P, et al.
Publicado em: (2005) -
In vitro dendritic cell generation and lymphocyte subsets in myeloma patients: influence of thalidomide and high-dose chemotherapy treatment.
por: Schütt, P, et al.
Publicado em: (2005) -
Immune parameters in multiple myeloma patients: influence of treatment and correlation with opportunistic infections.
por: Schütt, P, et al.
Publicado em: (2006) -
Thalidomide in combination with vincristine, epirubicin and dexamethasone (VED) for previously untreated patients with multiple myeloma.
por: Schütt, P, et al.
Publicado em: (2005)